{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T18:28:37Z","timestamp":1782239317292,"version":"3.54.5"},"reference-count":44,"publisher":"Public Library of Science (PLoS)","issue":"1","license":[{"start":{"date-parts":[[2009,1,13]],"date-time":"2009-01-13T00:00:00Z","timestamp":1231804800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0004180","type":"journal-article","created":{"date-parts":[[2009,1,12]],"date-time":"2009-01-12T22:30:18Z","timestamp":1231799418000},"page":"e4180","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":41,"title":["A Novel Replication-Competent Vaccinia Vector MVTT Is Superior to MVA for Inducing High Levels of Neutralizing Antibody via Mucosal Vaccination"],"prefix":"10.1371","volume":"4","author":[{"given":"Xiaoxing","family":"Huang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ke","family":"Zhuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tingting","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Po","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiwei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2009,1,13]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1038\/scientificamerican1076-25","article-title":"The eradication of smallpox.","volume":"235","author":"DA Henderson","year":"1976","journal-title":"Sci Am"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1056\/NEJM200208293470913","article-title":"Responses to smallpox vaccine.","volume":"347","author":"MA Sauri","year":"2002","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/S1201-9712(04)00133-X","article-title":"Smallpox containment updated: considerations for the 21st century.","volume":"8","author":"DL Heymann","year":"2004","journal-title":"Int J Infect Dis"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1038\/354520a0","article-title":"Large-scale eradication of rabies using recombinant vaccinia-rabies vaccine.","volume":"354","author":"B Brochier","year":"1991","journal-title":"Nature"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/0264-410X(89)90266-1","article-title":"Prospects for the total eradication of rinderpest.","volume":"7","author":"TD Yilma","year":"1989","journal-title":"Vaccine"},{"key":"ref6","first-page":"25","article-title":"Poxvirus expression vectors.","volume":"158","author":"B Moss","year":"1992","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref7","first-page":"495","article-title":"Vaccinia virus: a selectable eukaryotic cloning and expression vector. 1982.","volume":"24","author":"M Mackett","year":"1992","journal-title":"Biotechnology"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1038\/320537a0","article-title":"Expression of AIDS virus envelope gene in recombinant vaccinia viruses.","volume":"320","author":"SL Hu","year":"1986","journal-title":"Nature"},{"key":"ref9","first-page":"159","article-title":"Highly attenuated poxvirus vectors: NYVAC, ALVAC and TROVAC.","volume":"84","author":"E Paoletti","year":"1995","journal-title":"Dev Biol Stand"},{"key":"ref10","first-page":"6917","article-title":"Immunogenicity and safety of a recombinant vaccinia virus vaccine expressing the carcinoembryonic antigen gene in a nonhuman primate.","volume":"52","author":"J Kantor","year":"1992","journal-title":"Cancer Res"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jviromet.2007.03.012","article-title":"The attenuation of vaccinia Tian Tan strain by the removal of the viral M1L-K2L genes.","volume":"144","author":"W Zhu","year":"2007","journal-title":"J Virol Methods"},{"key":"ref12","first-page":"188","article-title":"Selection of recombinant vaccinia viruses (Tian Tan strain) expressing hepatitis B virus surface antigen by using beta-galactosidase as a marker.","volume":"33","author":"GQ Liu","year":"1990","journal-title":"Sci China B"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1099\/0022-1317-68-10-2587","article-title":"Expression and characterization of herpes simplex virus type 1 (HSV-1) glycoprotein G (gG) by recombinant vaccinia virus: neutralization of HSV-1 infectivity with anti-gG antibody.","volume":"68(Pt 10)","author":"V Sullivan","year":"1987","journal-title":"J Gen Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"2678","DOI":"10.1128\/JVI.79.5.2678-2688.2005","article-title":"Recombinant modified vaccinia virus Ankara expressing the spike glycoprotein of severe acute respiratory syndrome coronavirus induces protective neutralizing antibodies primarily targeting the receptor binding region.","volume":"79","author":"Z Chen","year":"2005","journal-title":"J Virol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"6641","DOI":"10.1073\/pnas.0401939101","article-title":"Severe acute respiratory syndrome coronavirus spike protein expressed by attenuated vaccinia virus protectively immunizes mice.","volume":"101","author":"H Bisht","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref16","first-page":"125","article-title":"Different contribution of co-stimulatory molecules B7.1 and B7.2 to the immune response to recombinant modified vaccinia virus ankara vaccine expressing prM\/E proteins of Japanese encephalitis virus and two hepatitis B virus vaccines.","volume":"51","author":"JH Nam","year":"2007","journal-title":"Acta Virol"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"4213","DOI":"10.1016\/j.vaccine.2007.02.084","article-title":"Generation and evaluation of a recombinant modified vaccinia virus Ankara vaccine for rabies.","volume":"25","author":"J Weyer","year":"2007","journal-title":"Vaccine"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.1058915","article-title":"Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA\/MVA vaccine.","volume":"292","author":"RR Amara","year":"2001","journal-title":"Science"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1089\/0889222041217428","article-title":"Multiprotein HIV type 1 clade B DNA and MVA vaccines: construction, expression, and immunogenicity in rodents of the MVA component.","volume":"20","author":"LS Wyatt","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"8874","DOI":"10.1016\/j.vaccine.2007.08.066","article-title":"Mucosal priming with replicative Tiantan vaccinia and systemic boosting with DNA vaccine raised strong mucosal and systemic HIV-specific immune responses.","volume":"25","author":"X Huang","year":"2007","journal-title":"Vaccine"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/QAI.0b013e3181651bb2","article-title":"Design, Construction, and Characterization of a Multigenic Modified Vaccinia Ankara Candidate Vaccine Against Human Immunodeficiency Virus Type 1 Subtype C\/B&apos;.","volume":"47(4)","author":"Z Chen","year":"2008","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.vaccine.2004.05.015","article-title":"Protective and disease-enhancing immune responses induced by recombinant modified vaccinia Ankara (MVA) expressing respiratory syncytial virus proteins.","volume":"23","author":"W Olszewska","year":"2004","journal-title":"Vaccine"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/nature02331","article-title":"Immunogenicity of a highly attenuated MVA smallpox vaccine and protection against monkeypox.","volume":"428","author":"PL Earl","year":"2004","journal-title":"Nature"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"7713","DOI":"10.1128\/JVI.76.15.7713-7723.2002","article-title":"Immunogenicity and safety of defective vaccinia virus lister: comparison with modified vaccinia virus Ankara.","volume":"76","author":"BT Ober","year":"2002","journal-title":"J Virol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1086\/517614","article-title":"Recombinant modified vaccinia virus Ankara-based vaccine induces protective immunity in mice against infection with influenza virus H5N1.","volume":"195","author":"JH Kreijtz","year":"2007","journal-title":"J Infect Dis"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"4818","DOI":"10.1016\/j.vaccine.2007.04.002","article-title":"Vaccination with recombinant modified vaccinia virus Ankara expressing bovine respiratory syncytial virus (bRSV) proteins protects calves against RSV challenge.","volume":"25","author":"AF Antonis","year":"2007","journal-title":"Vaccine"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1089\/aid.2004.20.1335","article-title":"DNA\/MVA vaccine for HIV type 1: effects of codon-optimization and the expression of aggregates or virus-like particles on the immunogenicity of the DNA prime.","volume":"20","author":"JM Smith","year":"2004","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1099\/vir.0.82493-0","article-title":"Clinical experience with plasmid DNA- and modified vaccinia virus Ankara-vectored human immunodeficiency virus type 1 clade A vaccine focusing on T-cell induction.","volume":"88","author":"T Hanke","year":"2007","journal-title":"J Gen Virol"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1476-9433-4-2","article-title":"The Future of Smallpox Vaccination: is MVA the key?","volume":"4","author":"MK Slifka","year":"2005","journal-title":"Med Immunol"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1086\/421266","article-title":"Modified vaccinia Ankara: potential as an alternative smallpox vaccine.","volume":"38","author":"LH McCurdy","year":"2004","journal-title":"Clin Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"2925","DOI":"10.1099\/vir.0.81181-0","article-title":"Recombinant poxviruses as mucosal vaccine vectors.","volume":"86","author":"MM Gherardi","year":"2005","journal-title":"J Gen Virol"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2174\/138161207781039832","article-title":"Mucosal vaccine vectors: replication-competent versus replication-deficient poxviruses.","volume":"13","author":"LU Karkhanis","year":"2007","journal-title":"Curr Pharm Des"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"8264","DOI":"10.1128\/JVI.72.10.8264-8272.1998","article-title":"Induction of a mucosal cytotoxic T-lymphocyte response by intrarectal immunization with a replication-deficient recombinant vaccinia virus expressing human immunodeficiency virus 89.6 envelope protein.","volume":"72","author":"IM Belyakov","year":"1998","journal-title":"J Virol"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.virol.2005.06.002","article-title":"Enhanced immunogenicity and protective effect conferred by vaccination with combinations of modified vaccinia virus Ankara and licensed smallpox vaccine Dryvax in a mouse model.","volume":"339","author":"CA Meseda","year":"2005","journal-title":"Virology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"4068","DOI":"10.1128\/JCM.41.9.4068-4070.2003","article-title":"Smallpox: residual antibody after vaccination.","volume":"41","author":"S Gallwitz","year":"2003","journal-title":"J Clin Microbiol"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1002\/pmic.200600926","article-title":"Proteome-wide analysis of the serological response to vaccinia and smallpox.","volume":"7","author":"DH Davies","year":"2007","journal-title":"Proteomics"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/nm917","article-title":"Duration of antiviral immunity after smallpox vaccination.","volume":"9","author":"E Hammarlund","year":"2003","journal-title":"Nat Med"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.virol.2005.02.014","article-title":"Host range, growth property, and virulence of the smallpox vaccine: vaccinia virus Tian Tan strain.","volume":"335","author":"Q Fang","year":"2005","journal-title":"Virology"},{"key":"ref39","first-page":"215","article-title":"DNA sequence analysis of the Hind III M fragment from Chinese vaccine strain of vaccinia virus.","volume":"4","author":"VJ Liu","year":"1989","journal-title":"Proc Chin Acad Med Sci Peking Union Med Coll"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1099\/0022-1317-66-8-1819","article-title":"Variation in the HindIII restriction fragments of DNA from the Chinese Tian Tan strain of vaccinia virus.","volume":"66(Pt 8)","author":"YT Hou","year":"1985","journal-title":"J Gen Virol"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1007\/s00253-007-1073-y","article-title":"Heterologous MVA-S prime Ad5-S boost regimen induces high and persistent levels of neutralizing antibody response against SARS coronavirus.","volume":"76","author":"L Ba","year":"2007","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"10684","DOI":"10.1128\/JVI.77.19.10684-10688.2003","article-title":"Development and use of a vaccinia virus neutralization assay based on flow cytometric detection of green fluorescent protein.","volume":"77","author":"PL Earl","year":"2003","journal-title":"J Virol"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/j.vaccine.2006.09.090","article-title":"Head-to-head comparison on the immunogenicity of two HIV\/AIDS vaccine candidates based on the attenuated poxvirus strains MVA and NYVAC co-expressing in a single locus the HIV-1BX08 gp120 and HIV-1(IIIB) Gag-Pol-Nef proteins of clade B.","volume":"25","author":"CE Gomez","year":"2007","journal-title":"Vaccine"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1099\/vir.0.82216-0","article-title":"Oral vaccination with modified vaccinia virus Ankara attached covalently to TMPEG-modified cationic liposomes overcomes pre-existing poxvirus immunity from recombinant vaccinia immunization.","volume":"88","author":"T Naito","year":"2007","journal-title":"J Gen Virol"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0004180","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,14]],"date-time":"2020-05-14T15:43:36Z","timestamp":1589471016000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0004180"}},"subtitle":[],"editor":[{"given":"Fu-Sheng","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2009,1,13]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2009,1,13]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0004180","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,1,13]]}}}